From pre-clinical to clinical imaging, bioimaging is one of the core capabilities that A*STAR has developed in the last decade. With the global ageing population and increased prevalence of diseases such as cardiovascular diseases, neurological disorders, metabolic diseases and other age-related diseases, there is a growing demand to advance imaging and diagnostic technologies.



DxD Hub

Launched in November 2014, the Diagnostics Development Hub (DxD Hub) is a national initiative led by A*STAR, through its commercialization arm A*ccelerate. It aims to fast track the transformation of the best diagnostic-related IPs globally into clinically validated and “registration-ready” diagnostic devices for adoption by start-ups, SMEs and MNCs. Located in Chromos, Biopolis, DxD Hub has obtained ISO13485 accreditation, signifying the Hub’s ability to develop products that meet customer, industrial and regulatory requirements. DxD Hub has developed a robust and diverse pipeline of projects based on an internally established process for project origination, scoping, evaluation and approval. Efforts are spearheaded by the Strategic Advisory Panel and Hub Evaluation Panel, and the Hub has since commenced project design and development activities for approved projects.